Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 1339 entries
Sorted by: Best Match Show Resources per page
Rationale, Design, and Baseline Characteristics of the Utopia Trial for Preventing Diabetic Atherosclerosis Using an SGLT2 Inhibitor: A Prospective, Randomized, Open-Label, Parallel-Group Comparative Study.

Diabetes therapy : research, treatment and education of diabetes and related disorders

Katakami N, Mita T, Yoshii H, Shiraiwa T, Yasuda T, Okada Y, Umayahara Y, Kaneto H, Osonoi T, Yamamoto T, Kuribayashi N, Maeda K, Yokoyama H, Kosugi K, Ohtoshi K, Hayashi I, Sumitani S, Tsugawa M, Ohashi M, Taki H, Nakamura T, Kawashima S, Sato Y, Watada H, Shimomura I.
PMID: 28864997
Diabetes Ther. 2017 Oct;8(5):999-1013. doi: 10.1007/s13300-017-0292-1. Epub 2017 Sep 01.

INTRODUCTION: Sodium-glucose co-transporter-2 (SGLT2) inhibitors are anti-diabetic agents that improve glycemic control with a low risk of hypoglycemia and ameliorate a variety of cardiovascular risk factors. The aim of the ongoing study described herein is to investigate the preventive...

Cite
Katakami N, Mita T, Yoshii H, et al. Rationale, Design, and Baseline Characteristics of the Utopia Trial for Preventing Diabetic Atherosclerosis Using an SGLT2 Inhibitor: A Prospective, Randomized, Open-Label, Parallel-Group Comparative Study. Diabetes Ther. 2017;8(5):999-1013doi: 10.1007/s13300-017-0292-1.
Katakami, N., Mita, T., Yoshii, H., Shiraiwa, T., Yasuda, T., Okada, Y., Umayahara, Y., Kaneto, H., Osonoi, T., Yamamoto, T., Kuribayashi, N., Maeda, K., Yokoyama, H., Kosugi, K., Ohtoshi, K., Hayashi, I., Sumitani, S., Tsugawa, M., Ohashi, M., Taki, H., Nakamura, T., Kawashima, S., Sato, Y., Watada, H., Shimomura, I. (2017). Rationale, Design, and Baseline Characteristics of the Utopia Trial for Preventing Diabetic Atherosclerosis Using an SGLT2 Inhibitor: A Prospective, Randomized, Open-Label, Parallel-Group Comparative Study. Diabetes therapy : research, treatment and education of diabetes and related disorders, 8(5), 999-1013. https://doi.org/10.1007/s13300-017-0292-1
Katakami, Naoto, et al. "Rationale, Design, and Baseline Characteristics of the Utopia Trial for Preventing Diabetic Atherosclerosis Using an SGLT2 Inhibitor: A Prospective, Randomized, Open-Label, Parallel-Group Comparative Study." Diabetes therapy : research, treatment and education of diabetes and related disorders vol. 8,5 (2017): 999-1013. doi: https://doi.org/10.1007/s13300-017-0292-1
Katakami N, Mita T, Yoshii H, Shiraiwa T, Yasuda T, Okada Y, Umayahara Y, Kaneto H, Osonoi T, Yamamoto T, Kuribayashi N, Maeda K, Yokoyama H, Kosugi K, Ohtoshi K, Hayashi I, Sumitani S, Tsugawa M, Ohashi M, Taki H, Nakamura T, Kawashima S, Sato Y, Watada H, Shimomura I. Rationale, Design, and Baseline Characteristics of the Utopia Trial for Preventing Diabetic Atherosclerosis Using an SGLT2 Inhibitor: A Prospective, Randomized, Open-Label, Parallel-Group Comparative Study. Diabetes Ther. 2017 Oct;8(5):999-1013. doi: 10.1007/s13300-017-0292-1. Epub 2017 Sep 01. PMID: 28864997; PMCID: PMC5630549.
Copy Download .nbib Format: NLM
Cost of Glycemic Target Achievement with Sodium Glucose Co-transporter 2 Inhibitors in Patients with Type 2 Diabetes in the UK.

Diabetes therapy : research, treatment and education of diabetes and related disorders

Evans M, Achha S, Neslusan C.
PMID: 28948541
Diabetes Ther. 2017 Oct;8(5):1175-1185. doi: 10.1007/s13300-017-0312-1. Epub 2017 Sep 25.

INTRODUCTION: Diabetes-related costs make up a large portion of healthcare expenditures in the UK. Many of these costs are related to treatment of diabetes-related complications. Reducing HbA1c to

Cite
Evans M, Achha S, Neslusan C. Cost of Glycemic Target Achievement with Sodium Glucose Co-transporter 2 Inhibitors in Patients with Type 2 Diabetes in the UK. Diabetes Ther. 2017;8(5):1175-1185doi: 10.1007/s13300-017-0312-1.
Evans, M., Achha, S., & Neslusan, C. (2017). Cost of Glycemic Target Achievement with Sodium Glucose Co-transporter 2 Inhibitors in Patients with Type 2 Diabetes in the UK. Diabetes therapy : research, treatment and education of diabetes and related disorders, 8(5), 1175-1185. https://doi.org/10.1007/s13300-017-0312-1
Evans, Marc, et al. "Cost of Glycemic Target Achievement with Sodium Glucose Co-transporter 2 Inhibitors in Patients with Type 2 Diabetes in the UK." Diabetes therapy : research, treatment and education of diabetes and related disorders vol. 8,5 (2017): 1175-1185. doi: https://doi.org/10.1007/s13300-017-0312-1
Evans M, Achha S, Neslusan C. Cost of Glycemic Target Achievement with Sodium Glucose Co-transporter 2 Inhibitors in Patients with Type 2 Diabetes in the UK. Diabetes Ther. 2017 Oct;8(5):1175-1185. doi: 10.1007/s13300-017-0312-1. Epub 2017 Sep 25. PMID: 28948541; PMCID: PMC5630566.
Copy Download .nbib Format: NLM
Effect of glycerol on sustained insulin release from PVA hydrogels and its application in diabetes therapy.

Experimental and therapeutic medicine

Cai Y, Che J, Yuan M, Shi X, Chen W, Yuan WE.
PMID: 27698690
Exp Ther Med. 2016 Oct;12(4):2039-2044. doi: 10.3892/etm.2016.3593. Epub 2016 Aug 12.

The present study aimed to investigate the effects of glycerol on the physical properties and release of an insulin-loaded polyvinyl alcohol (PVA) hydrogel film. The insulin-loaded hydrogel composite film was produced using the freeze-thawing method, after which the

Cite
Cai Y, Che J, Yuan M, et al. Effect of glycerol on sustained insulin release from PVA hydrogels and its application in diabetes therapy. Exp Ther Med. 2016;12(4):2039-2044doi: 10.3892/etm.2016.3593.
Cai, Y., Che, J., Yuan, M., Shi, X., Chen, W., & Yuan, W. E. (2016). Effect of glycerol on sustained insulin release from PVA hydrogels and its application in diabetes therapy. Experimental and therapeutic medicine, 12(4), 2039-2044. https://doi.org/10.3892/etm.2016.3593
Cai, Yunpeng, et al. "Effect of glycerol on sustained insulin release from PVA hydrogels and its application in diabetes therapy." Experimental and therapeutic medicine vol. 12,4 (2016): 2039-2044. doi: https://doi.org/10.3892/etm.2016.3593
Cai Y, Che J, Yuan M, Shi X, Chen W, Yuan WE. Effect of glycerol on sustained insulin release from PVA hydrogels and its application in diabetes therapy. Exp Ther Med. 2016 Oct;12(4):2039-2044. doi: 10.3892/etm.2016.3593. Epub 2016 Aug 12. PMID: 27698690; PMCID: PMC5038605.
Copy Download .nbib Format: NLM
The Effects of Transition from Bedtime to Morning Glargine Administration in Patients with Poorly Regulated Type 1 Diabetes Mellitus: Croatian Pilot Study.

Diabetes therapy : research, treatment and education of diabetes and related disorders

Gradiser M, Bilic-Curcic I, Djindjic B, Berkovic MC.
PMID: 26369657
Diabetes Ther. 2015 Dec;6(4):643-648. doi: 10.1007/s13300-015-0130-2. Epub 2015 Sep 14.

INTRODUCTION: The objective of this study was to compare differences in glucoregulation, frequency of hypoglycemic episodes, glucose variability and lipid profiles of inpatients with poorly regulated type 1 diabetes mellitus (T1DM) after evening versus morning glargine application.METHODS: Eighteen patients...

Cite
Gradiser M, Bilic-Curcic I, Djindjic B, et al. The Effects of Transition from Bedtime to Morning Glargine Administration in Patients with Poorly Regulated Type 1 Diabetes Mellitus: Croatian Pilot Study. Diabetes Ther. 2015;6(4):643-648doi: 10.1007/s13300-015-0130-2.
Gradiser, M., Bilic-Curcic, I., Djindjic, B., & Berkovic, M. C. (2015). The Effects of Transition from Bedtime to Morning Glargine Administration in Patients with Poorly Regulated Type 1 Diabetes Mellitus: Croatian Pilot Study. Diabetes therapy : research, treatment and education of diabetes and related disorders, 6(4), 643-648. https://doi.org/10.1007/s13300-015-0130-2
Gradiser, Marina, et al. "The Effects of Transition from Bedtime to Morning Glargine Administration in Patients with Poorly Regulated Type 1 Diabetes Mellitus: Croatian Pilot Study." Diabetes therapy : research, treatment and education of diabetes and related disorders vol. 6,4 (2015): 643-648. doi: https://doi.org/10.1007/s13300-015-0130-2
Gradiser M, Bilic-Curcic I, Djindjic B, Berkovic MC. The Effects of Transition from Bedtime to Morning Glargine Administration in Patients with Poorly Regulated Type 1 Diabetes Mellitus: Croatian Pilot Study. Diabetes Ther. 2015 Dec;6(4):643-648. doi: 10.1007/s13300-015-0130-2. Epub 2015 Sep 14. PMID: 26369657; PMCID: PMC4674472.
Copy Download .nbib Format: NLM
Sitagliptin Results in a Decrease of Truncated Apolipoprotein C1.

Diabetes therapy : research, treatment and education of diabetes and related disorders

Skinner NE, Wroblewski MS, Kirihara JA, Nelsestuen GL, Seaquist ER.
PMID: 26198273
Diabetes Ther. 2015 Sep;6(3):395-401. doi: 10.1007/s13300-015-0123-1. Epub 2015 Jul 22.

UNLABELLED: Apolipoprotein C1 (ApoC1) is a component of multiple lipoproteins where it performs a variety of roles in lipid metabolism and transport. ApoC1 exists as both full-length and truncated isoforms. Truncation of ApoC1 has been postulated to result from...

Cite
Skinner NE, Wroblewski MS, Kirihara JA, et al. Sitagliptin Results in a Decrease of Truncated Apolipoprotein C1. Diabetes Ther. 2015;6(3):395-401doi: 10.1007/s13300-015-0123-1.
Skinner, N. E., Wroblewski, M. S., Kirihara, J. A., Nelsestuen, G. L., & Seaquist, E. R. (2015). Sitagliptin Results in a Decrease of Truncated Apolipoprotein C1. Diabetes therapy : research, treatment and education of diabetes and related disorders, 6(3), 395-401. https://doi.org/10.1007/s13300-015-0123-1
Skinner, Nicole E B, et al. "Sitagliptin Results in a Decrease of Truncated Apolipoprotein C1." Diabetes therapy : research, treatment and education of diabetes and related disorders vol. 6,3 (2015): 395-401. doi: https://doi.org/10.1007/s13300-015-0123-1
Skinner NE, Wroblewski MS, Kirihara JA, Nelsestuen GL, Seaquist ER. Sitagliptin Results in a Decrease of Truncated Apolipoprotein C1. Diabetes Ther. 2015 Sep;6(3):395-401. doi: 10.1007/s13300-015-0123-1. Epub 2015 Jul 22. PMID: 26198273; PMCID: PMC4575309.
Copy Download .nbib Format: NLM
Cost-Effectiveness Analysis of d-Nav for People with Diabetes at High Risk of Neuropathic Foot Ulcers.

Diabetes therapy : research, treatment and education of diabetes and related disorders

Green W, Taylor M.
PMID: 27402392
Diabetes Ther. 2016 Sep;7(3):511-25. doi: 10.1007/s13300-016-0183-x. Epub 2016 Jul 11.

INTRODUCTION: The objective of this study was to assess the cost-effectiveness of the d-Nav Insulin Guidance Service (Hygieia Inc.), a system designed to improve glycemic control via the use of insulin titration, in people with diabetes at risk of...

Cite
Green W, Taylor M. Cost-Effectiveness Analysis of d-Nav for People with Diabetes at High Risk of Neuropathic Foot Ulcers. Diabetes Ther. 2016;7(3):511-25doi: 10.1007/s13300-016-0183-x.
Green, W., & Taylor, M. (2016). Cost-Effectiveness Analysis of d-Nav for People with Diabetes at High Risk of Neuropathic Foot Ulcers. Diabetes therapy : research, treatment and education of diabetes and related disorders, 7(3), 511-25. https://doi.org/10.1007/s13300-016-0183-x
Green, William, and Taylor, Matthew. "Cost-Effectiveness Analysis of d-Nav for People with Diabetes at High Risk of Neuropathic Foot Ulcers." Diabetes therapy : research, treatment and education of diabetes and related disorders vol. 7,3 (2016): 511-25. doi: https://doi.org/10.1007/s13300-016-0183-x
Green W, Taylor M. Cost-Effectiveness Analysis of d-Nav for People with Diabetes at High Risk of Neuropathic Foot Ulcers. Diabetes Ther. 2016 Sep;7(3):511-25. doi: 10.1007/s13300-016-0183-x. Epub 2016 Jul 11. PMID: 27402392; PMCID: PMC5014789.
Copy Download .nbib Format: NLM
Indian Injection Technique Study: Injecting Complications, Education, and the Health Care Professional.

Diabetes therapy : research, treatment and education of diabetes and related disorders

Kalra S, Mithal A, Sahay R, John M, Unnikrishnan AG, Saboo B, Ghosh S, Sanyal D, Hirsch LJ, Gupta V, Strauss KW.
PMID: 28289892
Diabetes Ther. 2017 Jun;8(3):659-672. doi: 10.1007/s13300-017-0244-9. Epub 2017 Mar 13.

INTRODUCTION: Using the Indian and rest of world (ROW) injection technique questionnaire (ITQ) data, we address key insulin injection complications.METHODS: In 2015 we conducted an ITQ survey throughout India involving 1011 patients. Indian values were compared with those from...

Cite
Kalra S, Mithal A, Sahay R, et al. Indian Injection Technique Study: Injecting Complications, Education, and the Health Care Professional. Diabetes Ther. 2017;8(3):659-672doi: 10.1007/s13300-017-0244-9.
Kalra, S., Mithal, A., Sahay, R., John, M., Unnikrishnan, A. G., Saboo, B., Ghosh, S., Sanyal, D., Hirsch, L. J., Gupta, V., & Strauss, K. W. (2017). Indian Injection Technique Study: Injecting Complications, Education, and the Health Care Professional. Diabetes therapy : research, treatment and education of diabetes and related disorders, 8(3), 659-672. https://doi.org/10.1007/s13300-017-0244-9
Kalra, Sanjay, et al. "Indian Injection Technique Study: Injecting Complications, Education, and the Health Care Professional." Diabetes therapy : research, treatment and education of diabetes and related disorders vol. 8,3 (2017): 659-672. doi: https://doi.org/10.1007/s13300-017-0244-9
Kalra S, Mithal A, Sahay R, John M, Unnikrishnan AG, Saboo B, Ghosh S, Sanyal D, Hirsch LJ, Gupta V, Strauss KW. Indian Injection Technique Study: Injecting Complications, Education, and the Health Care Professional. Diabetes Ther. 2017 Jun;8(3):659-672. doi: 10.1007/s13300-017-0244-9. Epub 2017 Mar 13. PMID: 28289892; PMCID: PMC5446373.
Copy Download .nbib Format: NLM
Injectable Coformulations in Diabetology.

Diabetes therapy : research, treatment and education of diabetes and related disorders

Kalra S, Gupta Y.
PMID: 25801349
Diabetes Ther. 2015 Jun;6(2):101-11. doi: 10.1007/s13300-015-0106-2. Epub 2015 Mar 24.

Coformulations are a novel pharmaceutical development in diabetology. They are composed of two medicinal products, both of which maintain their distinct pharmacokinetic and pharmacodynamic properties. Currently available coformulations include combinations of basal and rapid-acting insulin, and basal and glucagon-like...

Cite
Kalra S, Gupta Y. Injectable Coformulations in Diabetology. Diabetes Ther. 2015;6(2):101-11doi: 10.1007/s13300-015-0106-2.
Kalra, S., & Gupta, Y. (2015). Injectable Coformulations in Diabetology. Diabetes therapy : research, treatment and education of diabetes and related disorders, 6(2), 101-11. https://doi.org/10.1007/s13300-015-0106-2
Kalra, Sanjay, and Gupta, Yashdeep. "Injectable Coformulations in Diabetology." Diabetes therapy : research, treatment and education of diabetes and related disorders vol. 6,2 (2015): 101-11. doi: https://doi.org/10.1007/s13300-015-0106-2
Kalra S, Gupta Y. Injectable Coformulations in Diabetology. Diabetes Ther. 2015 Jun;6(2):101-11. doi: 10.1007/s13300-015-0106-2. Epub 2015 Mar 24. PMID: 25801349; PMCID: PMC4478180.
Copy Download .nbib Format: NLM
Identifying Patterns of Lifestyle Behaviors among People with Type 2 Diabetes in Tianjin, China: A Latent Class Analysis.

Diabetes therapy : research, treatment and education of diabetes and related disorders

Wang X, Chen J, Liu X, Gao F, Zhao H, Han D, Jing X, Liu Y, Cui Z, Li C, Ma J.
PMID: 29094299
Diabetes Ther. 2017 Dec;8(6):1379-1392. doi: 10.1007/s13300-017-0327-7. Epub 2017 Nov 01.

INTRODUCTION: Lifestyle behaviors are essential elements of diabetes care. The aims of this study were to identify distinct subgroups of people with type 2 diabetes based on personal levels of lifestyle behaviors and explore the different characteristics across these...

Cite
Wang X, Chen J, Liu X, et al. Identifying Patterns of Lifestyle Behaviors among People with Type 2 Diabetes in Tianjin, China: A Latent Class Analysis. Diabetes Ther. 2017;8(6):1379-1392doi: 10.1007/s13300-017-0327-7.
Wang, X., Chen, J., Liu, X., Gao, F., Zhao, H., Han, D., Jing, X., Liu, Y., Cui, Z., Li, C., & Ma, J. (2017). Identifying Patterns of Lifestyle Behaviors among People with Type 2 Diabetes in Tianjin, China: A Latent Class Analysis. Diabetes therapy : research, treatment and education of diabetes and related disorders, 8(6), 1379-1392. https://doi.org/10.1007/s13300-017-0327-7
Wang, Xuying, et al. "Identifying Patterns of Lifestyle Behaviors among People with Type 2 Diabetes in Tianjin, China: A Latent Class Analysis." Diabetes therapy : research, treatment and education of diabetes and related disorders vol. 8,6 (2017): 1379-1392. doi: https://doi.org/10.1007/s13300-017-0327-7
Wang X, Chen J, Liu X, Gao F, Zhao H, Han D, Jing X, Liu Y, Cui Z, Li C, Ma J. Identifying Patterns of Lifestyle Behaviors among People with Type 2 Diabetes in Tianjin, China: A Latent Class Analysis. Diabetes Ther. 2017 Dec;8(6):1379-1392. doi: 10.1007/s13300-017-0327-7. Epub 2017 Nov 01. PMID: 29094299; PMCID: PMC5688992.
Copy Download .nbib Format: NLM
Fasting, Diabetes, and Optimizing Health Outcomes for Ramadan Observers: A Literature Review.

Diabetes therapy : research, treatment and education of diabetes and related disorders

Almansour HA, Chaar B, Saini B.
PMID: 28181087
Diabetes Ther. 2017 Apr;8(2):227-249. doi: 10.1007/s13300-017-0233-z. Epub 2017 Feb 08.

INTRODUCTION: Globally, and in Australia, diabetes has become a common chronic health condition. Diabetes is also quite prevalent in culturally and linguistically diverse pockets of the Australian population, including Muslims. There are over 90 million Muslims with diabetes worldwide....

Cite
Almansour HA, Chaar B, Saini B. Fasting, Diabetes, and Optimizing Health Outcomes for Ramadan Observers: A Literature Review. Diabetes Ther. 2017;8(2):227-249doi: 10.1007/s13300-017-0233-z.
Almansour, H. A., Chaar, B., & Saini, B. (2017). Fasting, Diabetes, and Optimizing Health Outcomes for Ramadan Observers: A Literature Review. Diabetes therapy : research, treatment and education of diabetes and related disorders, 8(2), 227-249. https://doi.org/10.1007/s13300-017-0233-z
Almansour, Hadi A, et al. "Fasting, Diabetes, and Optimizing Health Outcomes for Ramadan Observers: A Literature Review." Diabetes therapy : research, treatment and education of diabetes and related disorders vol. 8,2 (2017): 227-249. doi: https://doi.org/10.1007/s13300-017-0233-z
Almansour HA, Chaar B, Saini B. Fasting, Diabetes, and Optimizing Health Outcomes for Ramadan Observers: A Literature Review. Diabetes Ther. 2017 Apr;8(2):227-249. doi: 10.1007/s13300-017-0233-z. Epub 2017 Feb 08. PMID: 28181087; PMCID: PMC5380495.
Copy Download .nbib Format: NLM
Efficacy and Safety of Insulin Degludec for Hyperglycemia Management in Noncritical Hospitalized Patients with Diabetes: An Observational Study.

Diabetes therapy : research, treatment and education of diabetes and related disorders

Simioni N, Filippi A, Scardapane M, Nicolucci A, Rossi MC, Frison V.
PMID: 28585180
Diabetes Ther. 2017 Aug;8(4):941-946. doi: 10.1007/s13300-017-0271-6. Epub 2017 Jun 05.

INTRODUCTION: To assess the efficacy and safety of insulin degludec administered in a basal-bolus regimen according to the GesTIO protocol in noncritical hospitalized patients with T1DM and T2DM.METHODS: Mean blood glucose levels (BG) and their standard deviations (SD) at...

Cite
Simioni N, Filippi A, Scardapane M, et al. Efficacy and Safety of Insulin Degludec for Hyperglycemia Management in Noncritical Hospitalized Patients with Diabetes: An Observational Study. Diabetes Ther. 2017;8(4):941-946doi: 10.1007/s13300-017-0271-6.
Simioni, N., Filippi, A., Scardapane, M., Nicolucci, A., Rossi, M. C., & Frison, V. (2017). Efficacy and Safety of Insulin Degludec for Hyperglycemia Management in Noncritical Hospitalized Patients with Diabetes: An Observational Study. Diabetes therapy : research, treatment and education of diabetes and related disorders, 8(4), 941-946. https://doi.org/10.1007/s13300-017-0271-6
Simioni, Natalino, et al. "Efficacy and Safety of Insulin Degludec for Hyperglycemia Management in Noncritical Hospitalized Patients with Diabetes: An Observational Study." Diabetes therapy : research, treatment and education of diabetes and related disorders vol. 8,4 (2017): 941-946. doi: https://doi.org/10.1007/s13300-017-0271-6
Simioni N, Filippi A, Scardapane M, Nicolucci A, Rossi MC, Frison V. Efficacy and Safety of Insulin Degludec for Hyperglycemia Management in Noncritical Hospitalized Patients with Diabetes: An Observational Study. Diabetes Ther. 2017 Aug;8(4):941-946. doi: 10.1007/s13300-017-0271-6. Epub 2017 Jun 05. PMID: 28585180; PMCID: PMC5544608.
Copy Download .nbib Format: NLM
Association Between Hypoglycemia and the Burden of Comorbidities in Hospitalized Vulnerable Older Diabetic Patients: A Cross-Sectional, Population-Based Study.

Diabetes therapy : research, treatment and education of diabetes and related disorders

de Decker L, Hanon O, Boureau AS, Chapelet G, Dibon C, Pichelin M, Berrut G, Cariou B.
PMID: 29086351
Diabetes Ther. 2017 Dec;8(6):1405-1413. doi: 10.1007/s13300-017-0319-7. Epub 2017 Oct 30.

INTRODUCTION: From a patient-centered perspective, the assessment of risk factors of hypoglycemia is of critical importance for the management of type 2 diabetes (T2D). However, the association between the occurrence of hypoglycemia and high burden of comorbidities has been...

Cite
de Decker L, Hanon O, Boureau AS, et al. Association Between Hypoglycemia and the Burden of Comorbidities in Hospitalized Vulnerable Older Diabetic Patients: A Cross-Sectional, Population-Based Study. Diabetes Ther. 2017;8(6):1405-1413doi: 10.1007/s13300-017-0319-7.
de Decker, L., Hanon, O., Boureau, A. S., Chapelet, G., Dibon, C., Pichelin, M., Berrut, G., & Cariou, B. (2017). Association Between Hypoglycemia and the Burden of Comorbidities in Hospitalized Vulnerable Older Diabetic Patients: A Cross-Sectional, Population-Based Study. Diabetes therapy : research, treatment and education of diabetes and related disorders, 8(6), 1405-1413. https://doi.org/10.1007/s13300-017-0319-7
de Decker, Laure, et al. "Association Between Hypoglycemia and the Burden of Comorbidities in Hospitalized Vulnerable Older Diabetic Patients: A Cross-Sectional, Population-Based Study." Diabetes therapy : research, treatment and education of diabetes and related disorders vol. 8,6 (2017): 1405-1413. doi: https://doi.org/10.1007/s13300-017-0319-7
de Decker L, Hanon O, Boureau AS, Chapelet G, Dibon C, Pichelin M, Berrut G, Cariou B. Association Between Hypoglycemia and the Burden of Comorbidities in Hospitalized Vulnerable Older Diabetic Patients: A Cross-Sectional, Population-Based Study. Diabetes Ther. 2017 Dec;8(6):1405-1413. doi: 10.1007/s13300-017-0319-7. Epub 2017 Oct 30. PMID: 29086351; PMCID: PMC5688985.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 1339 entries